Remdesivir is a broad-spectrum antiviral medication classified as a nucleoside analog that functions by inhibiting the viral RNA-dependent RNA polymerase, a mechanism essential for treating severe cases… Read more
Remdesivir is a broad-spectrum antiviral medication classified as a nucleoside analog that functions by inhibiting the viral RNA-dependent RNA polymerase, a mechanism essential for treating severe cases of COVID-19. This category provides an extensive range of reference standards, including impurities, metabolites, and stable isotope labelled compounds, which are critical for rigorous pharmaceutical analysis. Laboratory professionals utilize these materials for comprehensive impurity profiling, method validation, and quality control, ensuring that drug substances meet required safety and regulatory standards. By employing these well-characterized reference standards, researchers can perform accurate structural identification and quantitative assessment of Remdesivir throughout its development and manufacturing lifecycle. The availability of stable isotope labelled versions further enhances the sensitivity and precision of mass spectrometry-based analytical testing, facilitating reliable pharmacokinetic and metabolic studies. These high-quality materials are essential tools for maintaining consistency and compliance in pharmaceutical research and manufacturing environments.